This public procurement record has 2 releases in its history.

Award

22 Apr 2025 at 16:48

Tender

08 Nov 2024 at 12:00

Summary of the contracting process

The NHS Framework Agreement for Branded Medicines in the Proprietary Category Tender, facilitated by NHS England, is a public procurement process focused on pharmaceutical products. The procurement is being handled through an open procedure and falls under the "goods" category. The agreement is scheduled to run from 1st May 2025 to 30th April 2029, covering the entire UK region. The tender stage is currently active, with a submission deadline of 9th December 2024 at 13:00. This framework is notable for its significant value, amounting to £1,775,939,000, and it supports electronic submission methods through dedicated platforms.

This procurement presents substantial opportunities for businesses operating within the pharmaceutical industry, particularly those supplying branded medicines. Large companies and SMEs alike, such as Norgine Pharmaceuticals Limited and Novartis Pharmaceuticals UK Ltd, have successfully participated in similar NHS tenders and continue to provide value. SMEs in particular should consider this opportunity, given that NHS procurement processes often encourage SME participation, evidenced by the significant number of respondents from this segment. Businesses that utilise electronic systems for procurement and have robust delivery capabilities throughout the UK will find this framework advantageous for strategic growth and service expansion across NHS networks.

How relevant is this notice?

Notice Title

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Notice Description

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025<br/>Offer reference number: CM/PHR/22/5683<br/><br/>CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender:<br/>Period of Framework Agreement: 01 May 2025 to 30 April 2029

Lot Information

Lot 1

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025
Offer reference number: CM/PHR/22/5683

CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender:
Period of Framework Agreement: 01 May 2025 to 30 April 2029. Additional information: Price is not the only award criterion and all award criteria are stated only in the award documents

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04b505
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/016340-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,775,939,000 £1B-£10B
Lots Value
£1,775,939,000 £1B-£10B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
22 Apr 20251 years ago
Submission Deadline
9 Dec 2024Expired
Future Notice Date
Not specified
Award Date
24 Mar 20251 years ago
Contract Period
1 May 2025 - 30 Apr 2029 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
72
Supplier Names

Abbvie Ltd

Accord-UK Ltd

Alissa Healthcare Research Limited

Aspen Pharmacare UK Limited

Aspire Pharma Limited

Astellas Pharma Ltd

Aventis Pharma ltd t/a Sanofi

Baxter Healthcare Ltd

Bayer Plc

Besins Healthcare UK LTD

BioCryst Ireland Limited

CSL Behring UK Ltd

CST Pharma Limited

Celix Pharma Ltd.

Chiesi Limited

Colonis Pharma Ltd

Day Lewis Medical Ltd

Dexcel Pharma Ltd

Drugsrus Ltd

Eisai Ltd

Essential Pharma

Esteve Pharmaceuticals Ltd

FLYNN PHARMA LTD

Ferring Pharmaceuticals Ltd

G.L. Pharma UK Limited

Galen Limited

Gedeon Richter UK Ltd

Glenmark Pharmaceuticals Europe Limited

Grunenthal

INFECTOPHARM LTD

Ipsen

Janssen-Cilag Ltd

Kyowa Kirin International UK New Co Ltd

Lupin Healthcare (UK) Limited

Merck Serono Limited

Mercury Pharmaceuticals Limited

Merz

Morningside Pharmaeuticals

Mylan

Napp Pharmaceuticals Ltd

Neon Healthcare Ltd

Neuraxpharm UK Ltd

Nordic Pharma

Norgine Pharmaceuticals Limited

Novartis Pharmaceuticals UK Ltd

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Orifarm UK

Otsuka Pharmaceuticals UK Limited

Pfizer Ltd

Pharmasure

Pharming Group

Provepharm UK Ltd

ROVI Biotech Ltd

Rayner Surgical Group Ltd

Recordati Rare Diseases UK Ltd

Ridge Pharma

SERB SA

Sandoz Ltd

Selective Supplies Ltd.

Strandhaven Ltd t/a Somex Pharma

Sun Pharma UK Ltd

Synchrony

Takeda UK Ltd

Teva UK Limited

Theramex HQ UK

Thornton and Ross Ltd

Tillomed Laboratories ltd

Wockhardt UK Limited

Xiromed

Zentiva Pharma UK Ltd

medac Pharma LLP

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...